Wed, Aug 21, 2024
The partnership aims to accelerate the discovery and development of novel therapeutics, with each company leveraging its respective strengths and expertise.
More >
Mon, Jul 01, 2024
As benchmark indices edge higher after beginning the session flat, CLSA has revised its stance on five pharmaceutical stocks. The list includes names such as Dr. Reddy's Laboratories, Lupin, Gland Pharma, and others. Here is a revised list of pharma stocks by the brokerage.
Thu, May 11, 2023
The pharma company reported a consolidated net profit of Rs 960.1 crore for the quarter ended on March 31, 2023, implying a jump of 890 per cent or almost nine times year-on-year (YoY) from Rs 97 crore reported in the corresponding quarter of the previous fiscal.
Tue, Nov 01, 2022
Markets were volatile as the session witnessed a tussle between the bulls and bears where the former trumped the latter. The India VIX, a gauge for volatility in Nifty was up over 2 per cent at 16.13
Mon, Oct 31, 2022
Dr Reddy share price: Dr Reddy's stock was trading in green on both the indices with more than 1 per cent surge.
Stock Markets Highlights: Major Asian markets also started on a positive note on Monday with NIKKEI 225 trading at 27,465.60 or 1.33% higher from Friday closing levels while KOSPI was trading at 2,275.36, up 0.31%. Meanwhile, Shanghai Composite was trading with negative bias at 2,893.20, lower by 0.78%
Fri, Oct 28, 2022
Technical analyst Nilesh Jain suggests an avoid in this scrip citing that the stock has moved significantly in last few trading sessions
Tue, Oct 04, 2022
Bajaj Finance stock ended up 4.23 per cent on Tuesday or higher by 403 points from the Monday closing price. The gains for significant, Jain said adding that the stock must be bought on declines. The stock today closed at 7475 on the BSE. The risk to reward ratio is most favourable at levels around Rs 7300
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.